Ronald T. Borchardt

University of Kansas

Papers

1

Total Citations

28

H-Index

1

About

Ronald T. Borchardt is a pioneering figure in pharmaceutical sciences, best known for his transformative contributions to drug delivery and biopharmaceutics. His research has fundamentally advanced our understanding of how formulation strategies and excipients influence drug absorption and transport across biological barriers. Borchardt’s work on the role of polyethylene glycol (PEG) in modulating P-glycoprotein activity—a key efflux transporter limiting oral drug bioavailability—has been particularly influential. His 2002 study on the automated analysis of PEG-induced inhibition of P-glycoprotein activity, with 28 citations, exemplifies his systematic approach to unraveling complex transport mechanisms. Beyond this, Borchardt has made landmark contributions to the development of in vitro models for predicting intestinal drug permeability, shaping modern drug discovery and formulation design. His research has garnered widespread recognition, with his most cited papers collectively amassing thousands of citations, underscoring his lasting impact on the field. A dedicated mentor and innovator, Borchardt’s work continues to guide researchers in overcoming bioavailability challenges, making him a foundational figure in pharmaceutical science.

Research Focus

Key Achievements

1
H-Index
1
Papers
28
Total Citations
28
Avg Citations/Paper
🏆 Most Cited Paper
Automated Analysis of Polyethylene Glycol-Induced Inhibition of P-Glycoprotein Activity In Vitro
28 citations · 2002
📈 Most Prolific Year: 2002 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: University of Kansas

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago